Guggenheim Capital’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.13M | Buy |
10,605
+3,690
| +53% | +$1.56M | 0.03% | 497 |
|
|
2026
Q1 | $3.27M | Sell |
6,915
-783
| -10% | -$394K | 0.03% | 558 |
|
|
2025
Q4 | $3.59M | Buy |
7,698
+1,594
| +26% | +$740K | 0.03% | 516 |
|
|
2025
Q3 | $2.6M | Sell |
6,104
-4,340
| -42% | -$1.68M | 0.02% | 611 |
|
|
2025
Q2 | $4M | Sell |
10,444
-120
| -1% | -$43.2K | 0.03% | 480 |
|
|
2025
Q1 | $3.65M | Buy |
10,564
+203
| +2% | +$65.3K | 0.03% | 494 |
|
|
2024
Q4 | $3.11M | Sell |
10,361
-13,343
| -56% | -$4.66M | 0.03% | 533 |
|
|
2024
Q3 | $9.63M | Sell |
23,704
-725
| -3% | -$265K | 0.07% | 321 |
|
|
2024
Q2 | $7.85M | Sell |
24,429
-14,700
| -38% | -$4.78M | 0.06% | 382 |
|
|
2024
Q1 | $13.1M | Buy |
39,129
+542
| +1% | +$166K | 0.09% | 236 |
|
|
2023
Q4 | $10.4M | Sell |
38,587
-2,967
| -7% | -$733K | 0.08% | 298 |
|
|
2023
Q3 | $10.2M | Buy |
41,554
+14,691
| +55% | +$4.02M | 0.09% | 262 |
|
|
2023
Q2 | $8.15M | Sell |
26,863
-3,964
| -13% | -$1.1M | 0.06% | 358 |
|
|
2023
Q1 | $8.13M | Buy |
30,827
+5,546
| +22% | +$1.41M | 0.07% | 342 |
|
|
2022
Q4 | $6.07M | Sell |
25,281
-2,584
| -9% | -$579K | 0.05% | 454 |
|
|
2022
Q3 | $5.12M | Buy |
27,865
+3,977
| +17% | +$792K | 0.05% | 498 |
|
|
2022
Q2 | $4.01M | Sell |
23,888
-34,867
| -59% | -$7.49M | 0.03% | 636 |
|
|
2022
Q1 | $14.7M | Buy |
58,755
+10,963
| +23% | +$2.75M | 0.09% | 268 |
|
|
2021
Q4 | $12.3M | Sell |
47,792
-8,030
| -14% | -$1.96M | 0.06% | 349 |
|
|
2021
Q3 | $13.5M | Sell |
55,822
-9,311
| -14% | -$2.28M | 0.08% | 274 |
|
|
2021
Q2 | $13.5M | Buy |
65,133
+5,509
| +9% | +$1.12M | 0.08% | 293 |
|
|
2021
Q1 | $11.2M | Sell |
59,624
-4,984
| -8% | -$879K | 0.07% | 321 |
|
|
2020
Q4 | $10.6M | Buy |
64,608
+953
| +1% | +$139K | 0.07% | 321 |
|
|
2020
Q3 | $7.94M | Sell |
63,655
-11,720
| -16% | -$1.45M | 0.06% | 359 |
|
|
2020
Q2 | $7.32M | Buy |
75,375
+5,829
| +8% | +$606K | 0.06% | 374 |
|
|
2020
Q1 | $6.25M | Sell |
69,546
-11,816
| -15% | -$1.53M | 0.06% | 358 |
|
|
2019
Q4 | $12M | Buy |
81,362
+5,476
| +7% | +$735K | 0.09% | 267 |
|
|
2019
Q3 | $9.14M | Buy |
75,886
+7,893
| +12% | +$1.02M | 0.07% | 344 |
|
|
2019
Q2 | $9.19M | Sell |
67,993
-5,016
| -7% | -$634K | 0.07% | 321 |
|
|
2019
Q1 | $9.52M | Sell |
73,009
-3,062
| -4% | -$411K | 0.08% | 302 |
|
|
2018
Q4 | $9.47M | Buy |
76,071
+2,721
| +4% | +$365K | 0.08% | 281 |
|
|
2018
Q3 | $10.2M | Buy |
73,350
+11,584
| +19% | +$1.44M | 0.07% | 340 |
|
|
2018
Q2 | $6.34M | Sell |
61,766
-415,362
| -87% | -$42M | 0.04% | 570 |
|
|
2018
Q1 | $46.3M | Sell |
477,128
-108,299
| -18% | -$10.5M | 0.11% | 368 |
|
|
2017
Q4 | $51.4M | Sell |
585,427
-94,662
| -14% | -$7.6M | 0.12% | 317 |
|
|
2017
Q3 | $54.1M | Buy |
680,089
+48,898
| +8% | +$3.93M | 0.13% | 248 |
|
|
2017
Q2 | $55M | Buy |
631,191
+82,237
| +15% | +$6.96M | 0.15% | 227 |
|
|
2017
Q1 | $48.9M | Sell |
548,954
-47,474
| -8% | -$3.96M | 0.13% | 290 |
|
|
2016
Q4 | $44.1M | Buy |
596,428
+67,360
| +13% | +$5.04M | 0.13% | 301 |
|
|
2016
Q3 | $40M | Buy |
529,068
+38,860
| +8% | +$2.98M | 0.12% | 277 |
|
|
2016
Q2 | $37.8M | Sell |
490,208
-3,443
| -0.7% | -$272K | 0.12% | 293 |
|
|
2016
Q1 | $38.5M | Sell |
493,651
-112,796
| -19% | -$7.88M | 0.12% | 267 |
|
|
2015
Q4 | $41M | Buy |
606,447
+51,951
| +9% | +$3.62M | 0.12% | 263 |
|
|
2015
Q3 | $42.9M | Sell |
554,496
-66,606
| -11% | -$5.9M | 0.13% | 214 |
|
|
2015
Q2 | $56.3M | Sell |
621,102
-33,134
| -5% | -$2.65M | 0.14% | 169 |
|
|
2015
Q1 | $49.2M | Buy |
654,236
+534,190
| +445% | +$38.4M | 0.12% | 261 |
|
|
2014
Q4 | $8.81M | Sell |
120,046
-176,815
| -60% | -$12.4M | 0.02% | 879 |
|
|
2014
Q3 | $20.9M | Buy |
296,861
+19,964
| +7% | +$1.32M | 0.05% | 631 |
|
|
2014
Q2 | $15.6M | Buy |
276,897
+206,285
| +292% | +$10.9M | 0.04% | 742 |
|
|
2014
Q1 | $3.71M | Sell |
70,612
-25,478
| -27% | -$1.27M | 0.01% | 1315 |
|
|
2013
Q4 | $4.58M | Sell |
96,090
-118,912
| -55% | -$5.5M | 0.01% | 1137 |
|
|
2013
Q3 | $9.19M | Buy |
215,002
+96,791
| +82% | +$3.78M | 0.03% | 870 |
|
|
2013
Q2 | $4.26M | Buy |
+118,211
| New | +$4.57M | 0.02% | 1126 |
|
Other funds holding HCA
Guggenheim Capital's HCA Position: Q2 2026 in Review
Guggenheim Capital increased its HCA Healthcare (HCA) stake by 53% in Q2 2026, buying an estimated $1.56M and bringing the position to 10,605 shares worth $4.13M. The position accounts for 0.03% of the portfolio, ranked #497.
Guggenheim Capital first reported a position in HCA in Q2 2013 and has held it in 53 quarters since. The position peaked at $56.3M in Q2 2015. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Guggenheim Capital held 10,605 shares of HCA Healthcare worth $4.13M as of Q2 2026.
- Guggenheim Capital bought 3,690 HCA Healthcare shares in Q2 2026, an estimated $1.56M.
- HCA Healthcare made up 0.03% of Guggenheim Capital's portfolio in Q2 2026, its #497 holding.
- Guggenheim Capital first reported a position in HCA Healthcare in Q2 2013 and has held it in 53 quarters since.
- Guggenheim Capital's HCA Healthcare position peaked at $56.3M in Q2 2015.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.